Sign in

Research summary ·

Fetal cardiac interventions versus expectant management in congenital heart disease: a systematic review and meta-analysis.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review pooled earlier studies of heart care before birth. It looked at unborn babies with heart defects present from birth. Some had a heart procedure in the womb. Others were watched and had no procedure. The team searched large databases up to 31 December 2025. They combined 11 studies with 775 fetuses: 418 treated and 357 not.

What they found

Live birth was not clearly different between the groups. Among babies born alive, 53 of 271 died after a procedure. In the watched group, 94 of 287 died. One procedure, called FAV, was also linked to fewer deaths. FAV that worked as planned did better than FAV that failed. Other procedures, called FPV and FASI, showed no clear effects.

What it means for patients

The authors say FAV was linked to fewer deaths after birth. FAV also hinted at both heart sides working, but not clearly. FAV that worked was linked to more live births. It was also linked to both heart sides working more often. For FPV and FASI, the authors say data are sparse. They see those results only as early clues.

Why it is not certain yet

All studies watched patients rather than sorting them by chance. Few studies compared FPV or FASI with no procedure. The overall results mixed procedures that worked and ones that failed. Not every study gave data on live birth or later outcomes. A review can only be as good as the studies in it.

Source

Fetal cardiac interventions versus expectant management in congenital heart disease: a systematic review and meta-analysis.

PubMed · PMID 42902283

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Congenital heart disease publications